CTRI/2018/05/014259尚未招募未知
Evaluation of safety and efficacy profile of Airborn Ultrasound in the Management of Type-2 Diabetes Mellitus and Associated Neurovascular Complications.
Ms Maser Electronics Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patients with type 2 diabetes
- •2. Patients with HbA1c >7.5%
- •3. Patients with/without diabetic neuropathy
- •5. Patients willing to give written informed consent.
排除标准
- •1. Patient with type 1 diabetes
- •2. Patientwith stents/pacemaker/CABG/advance cardiomyopathy
- •3. Patients with hepatic diseases
- •4. Patients with chronic kidney diseases
- •5. Patient taking immunosuppressive medications, glucocorticoids
- •6. Patient with chronic alcoholism/drug abuse
- •7. Pregnant & lactating women
- •8. Patients not willing to come for follow up as per protocol.
- •9. Patients who have participated in any other clinical study over the past 3 months.
研究者
相似试验
招募中
2 期
Evaluation of safety and the effectiveness of Bioba (Prime) anti-hair loss line (serum and shampoo)IRCT20190210042676N16Akhavi laboratory19
尚未招募
1 期
Evaluation of the effectiveness and safety of bianshi moxibustion infrared dry eye therapeutic instrument in the treatment of meibomian gland dysfunctiomeibomian gland dysfunctionITMCTR1900002769Peking University Third Hospital
招募中
4 期
A Safety and Efficacy study of BOTOX® (Botulinum Toxin Type A) in patients with Urinary Incontinence due to bladder conditions.CTRI/2015/11/006353Allergan Healthcare India Pvt Ltd250
尚未招募
2 期
To Study the effects of Unani formulation Habb e Mujarrab in patients with Migraine without auraCTRI/2023/03/050748Central Council for Research in Unani Medicine New Delhi
已完成
2 期
The evaluation of the efficacy and safety on Bortezomib and Dexamethasone (BD therapy) using auto-PBSCT treatment after Vincristine,Doxorubicin and examethasone (VAD treatment) registanced multiple myeloma patients.(JMSG-0901)Multiple myeloma.JPRN-UMIN000002285Japanese Society of Myeloma40